Lung Cancer;Immunotherapy;Non Small Cell Lung Cancer;perioperative outcomes

ESMO: Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer

[ad_1] Newswise — MADRID ― Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery…